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a distance >4% from all HBV/D subgenotypes and recombinants,
suggesting a new HBV/D subgenotype . “Putative recombination
between genotypes A and E was observed in a single isolate from
the coastal region (Figure 3a), while putative genotype D/E recom-
binantswere observed in 2 isolates from thewestern region (Figure
3b).”
Conclusion: Despite of the availability of a stable HBV vaccine,
the Prevalence of the viruswas high among jaundice patients seek-
ing health care. Genotype A1 is the predominant genotype in Kenya
and in the Western region there are D/E. recombinants. Finding
of the novel HBV recombinant strains in Kenya indicates that fur-
ther investigation is required as the morbidity and progression of
infection with such strains is not known.
http://dx.doi.org/10.1016/j.ijid.2016.02.957
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Molecular detection of enteroviruses in pigs in
Lagos, southwestern Nigeria
L.O. olayemi
College of Medicine, University of lagos, Nigeria ,
Lagos, Nigeria
Background: Enteroviruses infect numerous mammalian
species including humans, Non-Human Primates (NHP), sheeps,
cows and pigs. Infections in pigs are mostly asymptomatic but can
sometimes be severe and occasionally fatal. Enteroviruses in pigs
are associated with a wide array of clinical presentations such as
reproductive failure, diarrhoea and neurological disorders.
Methods & Materials: This study detected the enterovirus RNA
from pigs in Ikeja Local Government Area of Lagos State, South-
westernNigeria froma total of 110 (60 nasal and 50 feacal) samples
from apparently healthy pigs in a major piggery between February
and March, 2015 using reverse transcriptase polymerase chain
reaction (RT-PCR). Ampliﬁcation and detection were carried out to
obtain enterovirus RNA speciﬁc bands of 154bp after agarose gel
electrophoresis.
Results: Only 1 (0.9%) Enterovirus RNA positivity for specie and
genus speciﬁc VP1 genewas detected from this study. Although the
prevalence of Enteroviruses in pigs from this study is relatively low.
Conclusion: This still indicates a potential source of transmis-
sion to pig handlers, consumers and the general public at large.
However, the continued surveillance of Enterovirus with the pos-
sibility of a wider coverage of the different regions within the state
and the country at large is solicited.
http://dx.doi.org/10.1016/j.ijid.2016.02.958
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Diarrhea in adult patients with inﬂuenza B
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1 Rostov State Medical University, Rostov-on-Don,
Russian Federation
2 Municipal hospital #1 named after N.A. Semashko,
Rostov-on-Don, Russian Federation
3 I.M. Sechenov First Moscow State Medical
University, Moscow, Russian Federation
Background: During 2014-2015 season we observed 147 cases
of inﬂuenza. 34% cases were patients with inﬂuenza B, 49% -
patients with several strains of inﬂuenza A/H3N2 and 17% - with
inﬂuenza A/H1N1pdm2009.
Methods & Materials: Diagnosis was conﬁrmed by PCR in nasal
swabs. All patients received treatment in the centralmunicipal hos-
pital of Rostov-on-Do,. Diarrhea was not recorded in patients with
inﬂuenza A. 24% of patients with inﬂuenza B (12 cases) demon-
strated diarrhea in the early stage of disease.
Results: All patients were women in the 50- to 65-year-old age
group with the exception of the 26 year old pregnant woman who
was an intravenous drug user. In all cases, patients had no epidemi-
ological link and were hospitalized in a different period of time. In
all cases the disease started with a fever up to 38.5 – 39 degrees C,
weakness, headache. After a few hours of the onset of symptoms.
1-3 times vomiting developed in 42% of cases. Also, liquid stool
without pathological admixtures 4-7 times a day throughout 2-3
days was recorded in 100% of patients since the ﬁrst day of disease.
Beforehospitalization83%patientswere treatedwith antipyret-
ics. Patients admitted to the hospital on 1-2 day of disease with the
preliminary diagnosis of acute infectious diarrhea.
Within 1-2 days of treatment in hospital dyspeptic symptoms
disappeared and catarrhal symptoms started to dominate in the
clinical picture of the disease: nasal congestion, sore throat, dry
and wet cough. All patients with diarrhea had level of WBC count
between 3.0-3.5 × 109/L observed on the 2-3 day and 7-8 day
of disease, radiological signs of acute bronchitis or bronchopneu-
monia were detected in 92% cases. Bacteriological investigation
of feces did not detect any pathogenic enterobacteria, rotavirus
and norovirus rapid tests and PCR on enterovirus were also neg-
ative. Mild or moderate dysbiosis of intestinal ﬂora was detected
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in 100% cases. All patients were treated with crystalloids, sorbents,
croseltamivir and antibiotics.
Conclusion:Weassume that diarrhea in patientswith inﬂuenza
B in majority of cases associated with the development or worsen-
ing of common immunosuppression and dysbiotic changes in the
intestine. It is often associated with bacterial complications.
http://dx.doi.org/10.1016/j.ijid.2016.02.959
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Thrombocytopenia and anti-platelet antibodies
in patients with chronic hepatitis C
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1 Rostov State Medical University, Rostov-on-Don,
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Background: One of the key position in hemostasis belongs to
surface platelet receptors (SPR) - glycoproteins (GP) Ia/IIa, Ib/IX and
IIb/IIIa. Antibodies to SPR can lead to development of thrombocy-
topenia in patients with chronic HCV-infection. However the role
of different types of antibodies in this process is unknown.
Aim: to estimate the role of different types of antibodies to sur-
face platelet receptors in HCV-associated thrombocytopenia.
Methods & Materials: he detection GP Ia/IIa, Ib/IX and IIb/IIIa
was made by the ELISA technique in patients with HCV and
thrombocytopenia (group 1, n=29), HCV without thrombocytope-
nia (group 2, n=28) and healthy people (group 3, n=32). All patients
were untreated with interferon and ribavirin.
Results: Anti-GP Ia/IIa were detected in 44,8±9,2% in 1th group,
3,6 ± 3,5% in 2th group, 12,5±5,8% in 3th group, p1-2<0,01, p1-
3<0,05. Anti-GP Ib/IX were indicated in 55,2±9,2% in 1th group,
10,7±5,8% in 2th group, and 28,1±7,9% in 3th group, p1-2<0,01,
p1-3<0,05. Anti- GP IIb/IIIa were recorded in the same groups in
24,1±8,0%, 17,8±7,3% and 25±7,6% accordingly without any statis-
tical difference (Fig. 1).
Mean optical density (MOD) of anti-GPIa/IIa in 1th group also
was more signiﬁcant than in 2th and 3th group (0,331±0,035,
0,208±0,015 and 0,217±0,012 accordingly, p1-2<0,01, p1-3<0,01).
More high level of anti- GPIb/IX MOD was also recorded in 1th
group than in 2th group (0,280±0,025 and 0,215±0,010 p<0,05),
no statistical evidence was found between 3th group and patients
in 1th and 2th groups. Investigation of anti-GP IIb/IIIa MOD also
Fig. 1. Frequencyof detection the antibodies toplatelet antigensGP IIb/IIIa, GP Ib/IX,
GPIa/IIa in different groups.
Fig. 2. Relative concentration of anti-platelet in different groups.
did not ﬁnd any statistical difference between patients with HCV-
infected patients (both groups) and healthy people (Fig. 2)
Conclusion: High frequency of revealing and signiﬁcant level
of MOD of anti-GP Ia/IIa и Ib/IX in HCV-infected patients with
thrombocytopenia demonstrated the evidence of damage in the
ﬁrst stages of primary hemostasis: adhesion of platelets to colla-
genwith support ofGP Ia/IIa and stabilizationof this aggregatewith
support of collagen-binding activity of GP Ib/IX (factor Von Wille-
brand) as well as more high risk of destruction platelets binding
with anti-GP Ia/IIa and anti- GP Ib/IX in spleen. Detection of anti-
GP Ia/IIa и Ib/IX can serve as prognostication criteria for developing
thrombocytopenia in patients with chronic HCV-infection.
http://dx.doi.org/10.1016/j.ijid.2016.02.960
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Indian experience with use of sofusbuvir for
treatment of hepatitis C virus infection:
Preliminary data from southern India
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Gangadharan, U.G. Zachariah, C.E. Eapen, P.
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Background: Hepatitis C virus (HCV) infection is a major health
problem worldwide. India has a burden of over 10 million HCV
chronic carriers. The previous standard of care for HCV was pegy-
lated IFN (Peg IFN) and ribavirin (RBV). The new direct acting
antivirals that are now available promise sustained virological
response, tolerability and higher cure rates. This study aims to
look at the response to sofosbuvir (SOF) (an NS5B nucleotide ana-
log) in combination with RBV with/ without Peg IFN among Indian
patients.
Methods & Materials: Plasma from 44 patients (including 5
post transplant) was obtained from those who were treated with
SOF and RBV ± PegIFN. RNA extraction and ampliﬁcation was done
using real time PCR. HCV genotypes were ascertained using the
NS5B region based sequencing. Samples were tested for RNA nega-
tivity, onemonthafter treatment initiation (RVR), and3 to6months
later.
Results: Thirty eight of 44 patients were genotyped. Genotype
distribution was 7(18.4%) for type 1, 28(73.7%)for type3, 3(9%) for
type 4 respectively. Patients with 1, 3 & 4 genotypes on additional
Peg IFN was 4(10.5%), 5(14.7%) & 1(2.94%) and without Peg IFN was
3(7.9%), 23(60.5%)&2(5.9%). RVR for all patientswas100%andat≥3
month follow up, there was 100% response to SOF based therapy.
RVR for the 5 post transplant patients was 100%.
